Pertuzumab Sigrima 420mg Injection Zydus

Pertuzumab Sigrima 420mg Injection Zydus Specification

Indication
HER2-positive breast cancer

Salt Composition
Pertuzumab 420mg/14ml

Dosage Form
Injection

Feature
Humanized monoclonal antibody

Ingredients
Pertuzumab

Application
Intravenous use

Physical Color/Texture
Clear to slightly opalescent

Fermentation Smell
Odorless

Storage Instructions
Store in refrigerator (2-8C), do not freeze

Shelf Life
24 months

Concentration
30 mg/ml

Packaging Type
Vial

Preservative Free
Yes

Single Use Vial
Yes

Route of Administration
IV infusion

Manufactured By
Zydus Healthcare

Prescription Required
Yes

Brand Name
Sigrima 420mg

Strength
420 mg

Container Volume
14 ml

Pertuzumab Sigrima 420mg Injection Zydus Trade Information

Minimum Order Quantity
1 Vial

Supply Ability
5000 Vials Per Month

Delivery Time
10 Days

About Pertuzumab Sigrima 420mg Injection Zydus

Unlock a matchless standard in oncology care with Pertuzumab Sigrima 420mg Injection from Zydus Healthcare. This famed humanized monoclonal antibody, expertly crafted for HER2-positive breast cancer, comes in a single-use, preservative-free IV vial. With a concentration of 30 mg/ml in a clear, odorless solution, it ensures remarkable efficacy and safety. Shop now to benefit from its advanced formulation, manufactured under strict protocols. Prescription required. Store at 2-8C and avoid freezing. Try now and experience exceptional quality, supplied by trusted exporters and traders in India.

Key Features and Site of Application

Pertuzumab Sigrima 420mg Injection is meticulously designed for intravenous infusion, ensuring targeted site-specific delivery. The injection comes in a clear, slightly opalescent solution, free from preservatives, amplifying patient safety. Its single-use design and odorless composition showcase premium manufacturing. With precise dosage and a user-friendly vial, it best matches hospital and clinical setups for seamless HER2-positive breast cancer treatment. The premixed format ensures easy administration and consistency.

Domestic Availability, Logistics, and Certifications

Stock ready for prompt dispatching, Pertuzumab Sigrima 420mg Injection Zydus is widely available across India's main domestic markets and leading hospitals. Sourced from trusted suppliers and backed by renowned certifications, each export batch is securely handled via certified FOB ports to guarantee safety and efficacy. Premium packaging and swift logistics underscore our commitment to delivering quality medicine, ensuring timely access for healthcare providers and wholesalers alike.

FAQ's of Pertuzumab Sigrima 420mg Injection Zydus:

Q: How should Pertuzumab Sigrima 420mg Injection be administered?

A: Pertuzumab Sigrima 420mg Injection should be administered via intravenous infusion under the supervision of a qualified healthcare professional, strictly following the prescribed dosage for HER2-positive breast cancer.

Q: What makes Pertuzumab Sigrima 420mg Injection by Zydus remarkable?

A: This injection is a humanized monoclonal antibody, known for its efficacy in treating HER2-positive breast cancer. It's preservative-free, single-use, and produced under stringent standards, ensuring safety and consistency.

Q: When should the product be stored and for how long?

A: The injection should always be stored in a refrigerator at 2-8C, away from freezing conditions. The product maintains its efficacy for up to 24 months from the date of manufacture.

Q: Where can healthcare providers procure Pertuzumab Sigrima 420mg Injection?

A: Healthcare providers, suppliers, and wholesalers in India can shop now through licensed pharmaceutical distributors or directly from Zydus Healthcare-authorized resellers.

Q: What are the main benefits of using this injection for patients?

A: This product offers targeted therapy for HER2-positive breast cancer, increasing treatment effectiveness with a premium, matchless formulation that minimizes risk of preservative-related adverse reactions.

Tell us about your requirement